These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

336 related articles for article (PubMed ID: 14666724)

  • 1. Immunotherapy and gene therapy of cancer using antibodies or their genes against tumor-associated antigens.
    Kuroki M; Shibaguchi H; Imakiire T; Uno K; Shirota K; Higuchi T; Shitama T; Yamada H; Hirose Y; Nagata A; Kuroki M
    Anticancer Res; 2003; 23(6a):4377-81. PubMed ID: 14666724
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Possible applications of antibodies or their genes in cancer therapy.
    Kuroki M; Huang J; Shibaguchi H; Tanaka T; Zhao J; Luo N; Hachimine K; Kinugasa T; Maekawa S; Enatsu S; Hamanaka W; Fukami T; Kuroki M
    Anticancer Res; 2006; 26(6A):4019-25. PubMed ID: 17195452
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tumor-targeting of viral vectors for cancer gene therapy by using antibodies or their genes against tumor-associated antigens.
    Kuroki M; Kuroki M; Shibaguchi H; Hachimine K; Kinugasa T; Badran A
    Anticancer Res; 2004; 24(5C):3373-7. PubMed ID: 15515434
    [TBL] [Abstract][Full Text] [Related]  

  • 4. New approaches to antibody therapy.
    Weiner LM; Adams GP
    Oncogene; 2000 Dec; 19(53):6144-51. PubMed ID: 11156528
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Engineering mouse monoclonal antibodies for cancer immunotherapy.
    Orlandi R
    Year Immunol; 1993; 7():69-73. PubMed ID: 8372514
    [No Abstract]   [Full Text] [Related]  

  • 6. Novel treatment strategies for cancer and their tumor-targeting approaches using antibodies against tumor-associated antigens.
    Kuroki M; Shirasu N
    Anticancer Res; 2014 Aug; 34(8):4481-8. PubMed ID: 25075090
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Potential clinical utility of monoclonal antibodies in the management of human carcinomas.
    Schlom J; Weeks MO
    Important Adv Oncol; 1985; ():170-92. PubMed ID: 3916739
    [No Abstract]   [Full Text] [Related]  

  • 8. Enhancement of antibody detection in cancer using panel of recombinant tumor-associated antigens.
    Zhang JY; Casiano CA; Peng XX; Koziol JA; Chan EK; Tan EM
    Cancer Epidemiol Biomarkers Prev; 2003 Feb; 12(2):136-43. PubMed ID: 12582023
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Recombinant bispecific antibodies for cellular cancer immunotherapy.
    Müller D; Kontermann RE
    Curr Opin Mol Ther; 2007 Aug; 9(4):319-26. PubMed ID: 17694444
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A prospect on cancer immunology.
    Kobayashi H
    Hokkaido Igaku Zasshi; 1979 Nov; 54(6):549-77. PubMed ID: 397163
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Anti-idiotype antibodies in cancer treatment.
    de Cerio AL; Zabalegui N; Rodríguez-Calvillo M; Inogés S; Bendandi M
    Oncogene; 2007 May; 26(25):3594-602. PubMed ID: 17530013
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Principles and use of anti-CTLA4 antibody in human cancer immunotherapy.
    Peggs KS; Quezada SA; Korman AJ; Allison JP
    Curr Opin Immunol; 2006 Apr; 18(2):206-13. PubMed ID: 16464564
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Technology evaluation: edrecolomab, Centocor Inc.
    Abicht A; Lochmüller H
    Curr Opin Mol Ther; 2000 Oct; 2(5):593-600. PubMed ID: 11249762
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Rational bases for new approaches to the therapy of pediatric solid tumors: immunotherapy and gene therapy].
    Pistoia V; Prigione I; Facchetti P; Corrias MV
    Pediatr Med Chir; 1994; 16(3):219-25. PubMed ID: 7971443
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tumor antigens as surrogate markers and targets for therapy and vaccines.
    Dalgleish A; Pandha H
    Adv Cancer Res; 2007; 96():175-90. PubMed ID: 17161680
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antigen choice in adoptive T-cell therapy of cancer.
    Offringa R
    Curr Opin Immunol; 2009 Apr; 21(2):190-9. PubMed ID: 19297140
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Contemporary molecular-biological methods of cancer diagnosis and monitoring based on the humoral immune response to tumor-associated antigens].
    Shebzukhov IuV; Belousov PV; Khlgatian SV; Sazykin AIu; Kuprash DV; Nedospasov SA
    Mol Gen Mikrobiol Virusol; 2007; (2):3-6. PubMed ID: 17600920
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Combinational adenovirus-mediated gene therapy and dendritic cell vaccine in combating well-established tumors.
    Xia D; Moyana T; Xiang J
    Cell Res; 2006 Mar; 16(3):241-59. PubMed ID: 16541123
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Novel antigenic markers of human tumor regression.
    Fareed GC; Mendiaz E; Sen A; Juillard GJ; Weisenburger TH; Totanes T
    J Biol Response Mod; 1988 Feb; 7(1):11-23. PubMed ID: 3373233
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antitumor effect of antibody against a SEREX-defined antigen (UOEH-LC-1) on lung cancer xenotransplanted into severe combined immunodeficiency mice.
    Mizukami M; Hanagiri T; Yasuda M; Kuroda K; Shigematsu Y; Baba T; Fukuyama T; Nagata Y; So T; Ichiki Y; Sugaya M; So T; Takenoyama M; Sugio K; Yasumoto K
    Cancer Res; 2007 Sep; 67(17):8351-7. PubMed ID: 17804751
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.